Clinical significance of early T‐cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children’s Cancer Study Group Study L99‐15
Year: 2011
Type: article
Abstract: Early T-cell precursor acute lymphoblastic leukaemia (ETP-ALL) is a recently identified subtype of T-ALL with distinctive gene expression and cell marker profiles, poor response to chemotherapy and a very high risk of relapse. We determined the reliability of restricted panel of cell markers to identify EPT-ALL using a previously classified cohort. Then, we applied the cell marker profile that best discriminated ETP-ALL to a cohort of 91 patients with T-ALL enrolled in the Tokyo Children's Cancer Study Group L99-15 study, which included allogeneic stem cell transplantation (allo-SCT) for patients with poor prednisone response. Five of the 91 patients (5·5%) met the ETP-ALL criteria. There were no significant differences in presenting clinical features between these and the remaining 86 patients. Response to early remission induction therapy was inferior in ETP-ALL as compared with T-ALL. The ETP-ALL subgroup showed a significantly poorer event-free survival (4-year rate; 40%) than the T-ALL subgroup (70%, P=0·014). Of note, three of four relapsed ETP-ALL patients survived after allo-SCT, indicating that allo-SCT can be effective for this drug-resistant subtype of T-ALL.
Source: British Journal of Haematology
Institutions: University of Yamanashi Hospital, University of Yamanashi, National Research Institute for Child Health and Development, St. Jude Children's Research Hospital, National University of Singapore, Saitama Children's Medical Center, The University of Tokyo, Saiseikai Yokohama-shi Nanbu Hospital, St. Luke's International Hospital, National Center For Child Health and Development, Yokohama City University, Ibaraki Children's Hospital, Toho University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: Molecular anlysis and development of targeting therapy in pediatric solid tumors by use of whole genomic and epigenomic resolution, Integrated molecular analyses of T cell acute lymphoblastic leukemia using SNP and methyration arrays, Genome wide analysis of imprinting gene in pediatric solid tumor, Whole genome and epigenome analysis of Juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome, Molecular analyses and the development of targeting therapy of pediatric acute myeloid leukemia using next generation sequencer
OpenAlex ID: W1578561002
